Ceo hyloris
WebHyloris Pharmaceuticals 4,887 followers on LinkedIn. We are committed to addressing unmet medical needs through reinventing existing medications We are a specialty … WebFeb 3, 2024 · For more information, please contact: Hyloris Pharmaceuticals. Stijn Van Rompay, CEO. Marieke Vermeersch, VP Investor Relations and Corporate Communications. +32 (0)4 346 02 07. investorrelations ...
Ceo hyloris
Did you know?
WebOct 1, 2024 · Hyloris Pharmaceuticals Stijn Van Rompay, CEO +32 (0)4 346 02 07 [email protected] Consilium Strategic Communications Amber Fennell, Chris Welsh, Taiana De Ruyck Soares +44 20 3709 5700 [email protected] . About Hyloris Pharmaceuticals SA Based in Liège, Belgium, Hyloris is an early-stage … WebMar 15, 2024 · Total general and administrative expenses amounted to €3.52 million versus €2.90 million last year and is mainly explained by additional communication and legal/HR costs. The company remains focus on strong cost and cash management. As a result, Hyloris closed 2024 with an operating loss of €10.64 million.
WebMay 26, 2024 · May 25, 2024, 10:00 PM. Hyloris Pharmaceuticals SA. (“Hyloris” or the “Company”) Hyloris appoints Patrick Jeanmart as Chief Financial Officer. Liège, Belgium – 26 May 2024: Hyloris ... WebSep 5, 2024 · Executive Summary. Hyloris CEO Stijn Van Rompay said the firm is on track to meet its target of 30 portfolio products by 2024, delivering a confident Q2 half-year …
WebOct 1, 2024 · Liège, Belgium – 1 October 2024: Hyloris Pharmaceuticals SA, an innovative specialty pharmaceutical company focused on adding value to the healthcare system by reformulating well-known pharmaceuticals, is pleased to announce the appointment of Dr. Dietmar Aichhorn as Chief Operating Officer, with effect from 1 October 2024. Dr. … Web4 hours ago · Du côté du BelSmall, Biocartis, qui a présenté son nouveau CEO, a gagné 5,4 pour cent, là où Ekopak a chuté de 4 pour cent. ... (ABM FN) Kepler Cheuvreux commencera le suivi de l'action Hyloris avec une recommandation d'achat et un objectif de cours de 17,00 euros. C'est ce qui est ressorti d'un rapport d'analyste publié jeudi.
WebNa een forse transformatie zet Home Invest Belgium zijn CEO Sven Janssens aan de deur. Hij is de derde CEO in tien jaar tijd die de beursgenoteerde woningverhuurder moet verlaten. ... Euronext Brussel: Fagron en Hyloris vergulden recessiepil. Björn Rzoska, de gematigde groene is de oppositie beu. Nieuws. Ondernemen. Vastgoed. Advertentie ...
WebJan 24, 2024 · Stijn Van Rompay, CEO [email protected] +32 (0)4 346 02 07 Jean-Luc Vandebroek, CFO [email protected] +32 (0)478 27 68 42 Sven Watthy, Investor Relations & Communications manager [email protected] +32 (0)499 71 15 29. Disclaimer and forward-looking statements. chemical properties for ironWebJan 24, 2024 · Stijn Van Rompay, CEO [email protected] +32 (0)4 346 02 07 Jean-Luc Vandebroek, CFO [email protected] +32 (0)478 27 68 42 … chemical properties meaning in foodWebSep 7, 2024 · Liège, Belgium – 7 September 2024 – Hyloris Pharmaceuticals SA (Euronext Brussels: HYL), an innovative specialty pharmaceutical company focused on adding value to the healthcare system by reformulating well-known pharmaceuticals, today announces the approval of Maxigesic® IV in eight European countries. Maxigesic® IV 1 is Hyloris ... flightaware hal 89WebJun 24, 2024 · Hyloris CEO and CBDO to resign from the Board of Directors of Alter Pharma. Liège, Belgium – 24 June 2024 – Hyloris Pharmaceuticals SA (Euronext … chemical properties of a bloody fingerprintWebHyloris Pharmaceuticals 4,786 followers on LinkedIn. We are committed to addressing unmet medical needs through reinventing existing medications We are a specialty biopharma company focused on … chemical properties in chemistryWebSep 5, 2024 · Executive Summary. Hyloris CEO Stijn Van Rompay said the firm is on track to meet its target of 30 portfolio products by 2024, delivering a confident Q2 half-year update despite some pushback from the US Food and Drug Administration on … chemical properties for hydrogenWebSep 23, 2024 · Jean-Luc will report to Hyloris’ CEO, and previously acting interim CFO, Stijn Van Rompay. Jean-Luc Vandebroek is a seasoned executive who most recently served as CFO of Bone Therapeutics, a ... flightaware hal90